MicroRNA-378 functions as an onco-miR in nasopharyngeal carcinoma by repressing TOB2 expression

International Journal of Oncology

Volumn 44, Issue 4, 2014, Pages 1215-1222

  Yu, Bo Long ^a   Peng, Xiao Hong ^a   Zhao, Fei Peng ^a   Liu, Xiong ^a   Lu, Juan ^a   Wang, Lu ^a   Li, Gang ^a   Chen, Huai Hong ^a   Li, Xiang Ping ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Invasion; MicroRNA 378; Nasopharyngeal carcinoma; Proliferation; Transducer of ERBB2

Indexed keywords

CELL CYCLE PROTEIN; MICRORNA; MIRN378 MICRORNA, HUMAN; TOB2 PROTEIN, HUMAN;

ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; CELL MOTION; CELL PROLIFERATION; CLINICAL TRIAL; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MOUSE; NASOPHARYNX TUMOR; NUDE MOUSE; TUMOR CELL LINE; TUMOR INVASION; TUMOR SUPPRESSOR GENE;

ANIMALS; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HUMANS; MICE; MICE, INBRED BALB C; MICE, NUDE; MICRORNAS; NASOPHARYNGEAL NEOPLASMS; NEOPLASM INVASIVENESS;

EID: 84894443582     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2014.2283     Document Type: Article

References (41)

1. Wei WI and Sham JS: Nasopharyngeal carcinoma. Lancet 365: 2041-2054, 2005.
2. Heng DM, Wee J, Fong KW, et al: Prognostic factors in 677 patients in Singapore with nondisseminated nasopharyngeal carcinoma. Cancer 86: 1912-1920, 1999.
3. Hong MH, Mai HQ, Min HQ, Ma J, Zhang EP and Cui NJ: A comparison of the Chinese 1992 and fifth-edition International Union Against Cancer staging systems for staging nasopharyngeal carcinoma. Cancer 89: 242-247, 2000.
4. Ma J, Mai HQ, Hong MH, et al: Is the 1997 AJCC staging system for nasopharyngeal carcinoma prognostically useful for Chinese patient populations? Int J Radiat Oncol Biol Phys 50: 1181-1189, 2001.
5. Ameres SL and Zamore PD: Diversifying microRNA sequence and function. Nat Rev Mol Cell Biol 14: 475-488, 2013.
6. Bartel DP: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297, 2004.
7. Calin GA, Sevignani C, Dumitru CD, et al: Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci USA 101: 2999-3004, 2004.
8. Jansson MD and Lund AH: MicroRNA and cancer. Mol Oncol 6: 590-610, 2012.
9. Zhang B, Pan X, Cobb GP and Anderson TA: microRNAs as oncogenes and tumor suppressors. Dev Biol 302: 1-12, 2007.
10. Wiemer EAC: The role of microRNAs in cancer: no small matter. Eur J Cancer 43: 1529-1544, 2007.
11. Sengupta S, den Boon JA, Chen IH, et al: MicroRNA 29c is down-regulated in nasopharyngeal carcinomas, up-regulating mRNAs encoding extracellular matrix proteins. Proc Natl Acad Sci USA 105: 5874-5878, 2008.
12. Yu L, Lu J, Zhang B, et al: miR-26a inhibits invasion and metastasis of nasopharyngeal cancer by targeting EZH2. Oncol Lett 5: 1223-1228, 2013.
13. Luo Z, Dai Y, Zhang L, et al: miR-18a promotes malignant progression by impairing microRNA biogenesis in nasopharyngeal carcinoma. Carcinogenesis 34: 415-425, 2013.
14. Liu Y, Cai H, Liu J, et al: A miR-151 binding site polymorphism in the 3'-untranslated region of the cyclin E1 gene associated with nasopharyngeal carcinoma. Biochem Biophys Res Commun 432: 660-665, 2013.
15. Li G, Liu Y, Su Z, et al: MicroRNA-324-3p regulates nasopharyngeal carcinoma radioresistance by directly targeting WNT2B. Eur J Cancer: Apr 10, 2013 (Epub ahead of print).
16. Deng M, Ye Q, Qin Z, et al: miR-214 promotes tumorigenesis by targeting lactotransferrin in nasopharyngeal carcinoma. Tumour Biol 34: 1793-1800, 2013.
17. Liu N, Chen N-Y, Cui R-X, et al: Prognostic value of a microRNA signature in nasopharyngeal carcinoma: a microRNA expression analysis. Lancet Oncol 13: 633-641, 2012.
18. Liu X, Luo HN, Tian WD, et al: Diagnostic and prognostic value of plasma microRNA deregulation in nasopharyngeal carcinoma. Cancer Biol Ther 14: Aug 23, 2013 (Epub ahead of print).
19. Jiang J, Lee EJ, Gusev Y and Schmittgen TD: Real-time expression profiling of microRNA precursors in human cancer cell lines. Nucleic Acids Res 33: 5394-5403, 2005.
20. Hua Z, Lv Q, Ye W, et al: MiRNA-directed regulation of VEGF and other angiogenic factors under hypoxia. PLoS One 1: e116, 2006.
21. Lee DY, Deng Z, Wang CH and Yang BB: MicroRNA-378 promotes cell survival, tumor growth, and angiogenesis by targeting SuFu and Fus-1 expression. Proc Natl Acad Sci USA 104: 20350-20355, 2007.
22. Eichner LJ, Perry MC, Dufour CR, et al: miR-378(*) mediates metabolic shift in breast cancer cells via the PGC-1β/ERRγ transcriptional pathway. Cell Metab 12: 352-361, 2010.
23. Faltejskova P, Svoboda M, Srutova K, et al: Identification and functional screening of microRNAs highly deregulated in colorectal cancer. J Cell Mol Med 16: 2655-2666, 2012.
24. Qian J, Lin J, Qian W, et al: Overexpression of miR-378 is frequent and may affect treatment outcomes in patients with acute myeloid leukemia. Leuk Res 37: 765-768, 2013.
25. Redova M, Poprach A, Nekvindova J, et al: Circulating miR-378 and miR-451 in serum are potential biomarkers for renal cell carcinoma. J Transl Med 10: 55, 2012.
26. Liu H, Zhu L, Liu B, et al: Genome-wide microRNA profiles identify miR-378 as a serum biomarker for early detection of gastric cancer. Cancer Lett 316: 196-203, 2012.
27. Yao Y, Suo AL, Li ZF, et al: MicroRNA profiling of human gastric cancer. Mol Med Rep 2: 963-970, 2009.
28. Guo J, Miao Y, Xiao B, et al: Differential expression of microRNA species in human gastric cancer versus nontumorous tissues. J Gastroenterol Hepatol 24: 652-657, 2009.
29. Deng H, Guo Y, Song H, et al: MicroRNA-195 and microRNA-378 mediate tumor growth suppression by epigenetical regulation in gastric cancer. Gene 518: 351-359, 2013.
30. Chen LT, Xu SD, Xu H, Zhang JF, Ning JF and Wang SF: MicroRNA-378 is associated with non-small cell lung cancer brain metastasis by promoting cell migration, invasion and tumor angiogenesis. Med Oncol 29: 1673-1680, 2012.
31. Wu QP, Xie YZ, Deng Z, et al: Ergosterol peroxide isolated from Ganoderma lucidum abolishes microRNA miR-378-mediated tumor cells on chemoresistance. PLoS One 7: e44579, 2012.
32. Sand M, Skrygan M, Sand D, et al: Expression of microRNAs in basal cell carcinoma. Br J Dermatol 167: 847-855, 2012.
33. Sand M, Skrygan M, Georgas D, et al: Microarray analysis of microRNA expression in cutaneous squamous cell carcinoma. J Dermatol Sci 68: 119-126, 2012.
34. Ambros V: The functions of animal microRNAs. Nature 431: 350-355, 2004.
35. Wang K, Zhang S, Marzolf B, et al: Circulating microRNAs, potential biomarkers for drug-induced liver injury. Proc Natl Acad Sci USA 106: 4402-4407, 2009.
36. Tanaka M, Oikawa K, Takanashi M, et al: Down-regulation of miR-92 in human plasma is a novel marker for acute leukemia patients. PLoS One 4: e5532, 2009.
37. Ikematsu N, Yoshida Y, Kawamura-Tsuzuku J, et al: Tob2, a novel anti-proliferative Tob/BTG1 family member, associates with a component of the CCR4 transcriptional regulatory complex capable of binding cyclin-dependent kinases. Oncogene 18: 7432-7441, 1999.
38. Suzuki T, K-Tsuzuku J, Ajima R, Nakamura T, Yoshida Y and Yamamoto T: Phosphorylation of three regulatory serines of Tob by Erk1 and Erk2 is required for Ras-mediated cell proliferation and transformation. Genes Dev 16: 1356-1370, 2002.
39. Boiko AD, Porteous S, Razorenova OV, Krivokrysenko VI, Williams BR and Gudkov AV: A systematic search for downstream mediators of tumor suppressor function of p53 reveals a major role of BTG2 in suppression of Ras-induced transformation. Genes Dev 20: 236-252, 2006.
40. Winkler GS: The mammalian anti-proliferative BTG/Tob protein family. J Cell Physiol 222: 66-72, 2010.
41. Feng M, Li Z, Aau M, Wong CH, Yang X and Yu Q: Myc/miR-378/TOB2/cyclin D1 functional module regulates oncogenic transformation. Oncogene 30: 2242-2251, 2011.